We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

Amgen (AMGN) concluded the recent trading session at $273.68, signifying a -1.3% move from its prior day's close.

The Pope's last day, Easter Sunday, was marked by an appearance on the Loggia balcony of St. Peter's Basilica, meeting the ...

Despite resilient demand, healthcare has taken a hit along with the rest of the market. Amgen could boost profits ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Amgen (AMGN – Research Report), with a price target of ...

Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen ...

Ian Thompson, SVP and general manager of U.S. business operations at Amgen, shares his leadership philosophy, what he's ...

Amgen profits rise, next MariTide studies start by mid-year Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug candidate ...

Cantor Fitzgerald initiated or transferred coverage on 10 large-cap U.S. biopharma stocks in a note Tuesday, highlighting a selective approach that favors dominant franchises with strong growth ...